Back to Journals » Stem Cells and Cloning: Advances and Applications » Volume 1

Stem cell horizons in intervertebral disc degeneration

Authors Ciacci J, Ho A, Ames CP, Jandial R

Published 20 January 2009 Volume 2008:1 Pages 31—39

DOI https://doi.org/10.2147/SCCAA.S2825

Joseph Ciacci1, Allen Ho1,2, Christopher P Ames3, Rahul Jandial4

1Division of Neurosurgery, University of California, San Diego, La Jolla, California, USA; 2Del E Webb Neurosciences, Aging and Stem Cell Research Center, The Burnham Institute for Medical Research, La Jolla, California, USA; 3Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA; 4Division of Neurosurgery, Department of Surgery, City of Hope Cancer Center, Duarte, CA, USA

Abstract: Intervertebral disc degeneration remains a pervasive and intractable disease arising from a combination of aging and stress on the back and spine. The growing field of regenerative medicine brings the promise of stem cells in the treatment of disc disease. Scientists and physicians hope to employ stem cells not only to stop, but also reverse degeneration. However, there are many important outstanding issues, including the hostile avascular, apoptotic physiological environment of the intervertebral disc, and the difficulty of obtaining mesenchymal stem cells, and directing them towards chondrocytic differentiation and integration within the nucleus pulposus of the disc. Given the recent advances in minimally invasive spine surgery, and developing body of work on stem cell manipulation and transplantation, stem cells are uniquely poised to bring about large-scale improvements in treatment and outcomes for degenerative disc disease. In this review we will first discuss the cellular and molecular factors influencing degeneration, and then examine the efficacy and difficulties of stem cell transplantation.

Keywords: intervertebral disc degeneration, stem cells, disc disease, mesenchymal stem cells, stem cell transplantation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

Stem cells and the origin of gliomas: A historical reappraisal with molecular advancements

Michael L Levy, Allen L Ho, Samuel Hughes, Jayant Menon, Rahul Jandial

Stem Cells and Cloning: Advances and Applications 2008, 1:41-47

Published Date: 20 January 2009

Readers of this article also read:

Mesenchymal stem cell therapy for osteoarthritis: current perspectives

Wyles CC, Houdek MT, Behfar A, Sierra RJ

Stem Cells and Cloning: Advances and Applications 2015, 8:117-124

Published Date: 28 August 2015

Lower extremity amputation in peripheral artery disease: improving patient outcomes

Swaminathan A, Vemulapalli S, Patel MR, Jones WS

Vascular Health and Risk Management 2014, 10:417-424

Published Date: 16 July 2014

Age-old wisdom concerning cell-based therapies with added knowledge in the stem cell era: our perspectives

Preethy S, John S, Ganesh JS, Srinivasan T, Terunuma H, Iwasaki M, Abraham SJ

Stem Cells and Cloning: Advances and Applications 2013, 6:13-18

Published Date: 4 April 2013

Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction

Anne-Laure Leblond, John O’Sullivan, Noel Caplice

Stem Cells and Cloning: Advances and Applications 2009, 2:11-19

Published Date: 4 December 2009

Stem cells and the origin of gliomas: A historical reappraisal with molecular advancements

Michael L Levy, Allen L Ho, Samuel Hughes, Jayant Menon, Rahul Jandial

Stem Cells and Cloning: Advances and Applications 2008, 1:41-47

Published Date: 20 January 2009

Defining the expression of marker genes in equine mesenchymal stromal cells

Deborah J Guest, Jennifer C Ousey, Matthew RW Smith

Stem Cells and Cloning: Advances and Applications 2008, 1:1-9

Published Date: 2 November 2008